Pelthos Therapeutics shareholders elect directors, approve waiver of convertible note share limit, ratify auditor

Pelthos Therapeutics Inc.

All seven director nominees elected with >2.24M 'For' votes each; broker non-votes of 278,134.
Shareholders approved waiver of share issuance limit under senior secured convertible notes (For 2,247,248, Against 3,474).
Ratified CBIZ CPAs as independent auditor for fiscal year ending Dec 31, 2025 (For 2,509,765, Against 19,091).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.